Fluindione-induced acute generalised exanthematous pustulosis confirmed by patch testing;Pustulose exanthématique aiguë généralisée à la fluindione (Préviscan®) avec tests épicutanés positifs

Annales de Dermatologie et de Venereologie

Volumn 135, Issue 4, 2008, Pages 295-298

  Chtioui, M ^a   Cousin Testard, F ^a   Zimmermann, U ^a   Amar, A ^b   Saiag, P ^a   Mahe E ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Acute generalised exanthematous pustulosis; Fluindione

Indexed keywords

FLUINDIONE; WARFARIN; DRUG DERIVATIVE; PHENINDIONE;

ABSENCE OF SIDE EFFECTS; AGED; ARTICLE; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; HEART ARRHYTHMIA; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; LABORATORY TEST; PATCH TEST; PUSTULOSIS; BULLOUS SKIN DISEASE; CHEMICALLY INDUCED DISORDER; DRUG ERUPTION; PATHOLOGY; RASH;

AGED; DRUG ERUPTIONS; EXANTHEMA; FEMALE; HUMANS; PATCH TESTS; PHENINDIONE; SKIN DISEASES, VESICULOBULLOUS;

EID: 50349090836     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2007.07.004     Document Type: Article

References (12)

1. Sidoroff A., Halevy S., Bouwes Bavinck J.N., Vaillant L., and Roujeau J.C. Acute generalized exanthematous pustulosis. A clinical reaction pattern. J Cutan Pathol 28 (2001) 113-119
2. Naisbitt D.J., Farrell J., Chamberlain P.J., Hopkins J.E., Berry N.G., Pirmohamed M., et al. Characterization of the T-cell response in a patient with phenindione hypersensitivity. J Pharmacol Exp Ther 313 (2005) 1058-1065
3. Sparsa A., Bédane C., Benazahary H., De Vencay P., Gauthier M.L., Le Brun V., et al. Syndrome d'hypersensibilité médicamenteuse à la fluindione. Ann Dermatol Venereol 128 (2001) 1014-1018
4. ®). Positivité des tests cutanés. Ann Dermatol Venereol 132 (2005) 1000-1002
5. Thurot C., Reymond J.L., Bourrain J.L., Pinel N., and Béani J.C. Pustulose exanthématique aiguë généralisée à la fluindione avec atteinte rénale. Ann Dermatol Venereol 130 (2003) 1146-1149
6. Penot J., Fontenelle P., and Dorleac D. Hépatite aiguë cytolytique asymptomatique à la fluindione s'accompagnant d'une résistance au traitement. Arch Mal Cœur 91 (1998) 267-270
7. Belmouaz S., Desport E., Abou-Ayache R., Thierry A., Mignot A., Bauwens M., et al. Acute immuno-allergic interstitial nephritis caused by fluindione. Clin Nephrol 66 (2006) 455-458
8. Stephan D., Simonnet N., Weltin D., Habersetzer F., Welsch M., and Imbs J.L. Cholestatic hepatitis caused by fluindione. Therapie 57 (2002) 589-590
9. Wolkenstein P., Chosidow O., Flechet M.L., Robbiola O., Paul M., Dume L., et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 35 (1996) 234-236
10. Barbaud A., Goncalo M., Bruynzeel D., and Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 45 (2001) 321-328
11. Barbaud A. Drug patch testing in systemic cutaneous drug allergy. Toxicology 209 (2005) 209-216
12. Spyropoulos A.C., Hayth K.A., and Jenkins P. Anticoagulation with anisindione in a patient with a warfarin-induced skin eruption. Pharmacotherapy 23 (2003) 533-536